Biogennix sets record month for July sales — 3 things to know

Written by Alan Condon | August 14, 2019 | Print  |

In July, orthobiologics company Biogennix hit its best ever month for sales since its formation in 2009.

Three things to know:

1. Biogennix designs, manufactures and distributes bone graft substitutes for bone fusion procedures.

2. The company is expanding its sales team, manufacturing capacity and research and development program.

3. Its bone grafting products — Morpheus and osteoSPAN — are resorbable, osteoconductive scaffolds that are used for bone regeneration.

More articles on devices:
Misonix ultrasonic device earns CE Mark approval — 4 insights
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure



© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months